Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia.

Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia.

Therapy-related acute myeloid leukemia (t-AML) in most cases develops after chemotherapy of other malignancies and shows characteristic chromosome aberrations. Two general types of t-AML have previously been identified. One type is observed after therapy with alkylating agents and characteristically...

书目详细资料
Main Authors:	Pedersen-Bjergaard, J, Andersen, M, Christiansen, D, Nerlov, C
格式:	Journal article
语言:	English
出版:	2002

相似书籍

TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA
由: Ugo Testa, et al.
出版: (2023-06-01)

Secondary acute myeloid leukemia and de novo acute myeloid leukemia with myelodysplasia-related changes - close or complete strangers?
由: Milan Jagurinoski, et al.
出版: (2023-10-01)

Acute myeloid leukemia with myelodysplasia-related changes and blasts of the mixed T/myeloid phenotype: a case report
由: Xian-Fu Sheng, et al.
出版: (2022-09-01)

Myelodysplasia-related acute myeloid leukemia and acute promyelocytic leukemia: concomitant occurrence of two molecularly distinct diseases
由: Yenny Alejandra Moreno Vanegas, et al.
出版: (2018-09-01)

Therapy-related leukemia and myelodysplasia: susceptibility and incidence
由: Giuseppe Leone, et al.
出版: (2007-10-01)

PB1823: SECONDARY ACUTE MYELOID LEUKEMIA AND DE NOVO ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES DISTINCT LANDSCAPE, OR THE SAME DISEASE?
由: M. Jagurinoski, et al.
出版: (2022-06-01)

Dismal outcome of refractory or relapsing patients with myelodysplasia‐related acute myeloid leukemia partially alleviated by intensive chemotherapy
由: Harmony Leroy, et al.
出版: (2024-02-01)

ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia‐related changes and normal karyotype
由: Concepción Prats‐Martín, et al.
出版: (2020-06-01)

Clinical Characteristics and Optimal Therapy of Acute Myeloid Leukemia with Myelodysplasia-Related Changes: A Retrospective Analysis of a Cohort of Chinese Patients
由: Lei Wang, et al.
出版: (2021-08-01)

Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia
由: Craddock, C, et al.
出版: (2013)

Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia.
由: Craddock, C, et al.
出版: (2013)

Modeling CEBPA Mutant Acute Myeloid Leukemias
由: Nerlov, C
出版: (2013)

Two novel germline DDX41 mutations in a family with inherited myelodysplasia/acute myeloid leukemia
由: Ruijuan Li, et al.
出版: (2016-06-01)

Acute abdominal pain due to atypical bilateral adrenal infarction in acute myeloid leukemia with alterations related to myelodysplasia: A case report
由: Risa Hirata, et al.
出版: (2023-10-01)

NFKB, TRAF6, AND MYDDOSOME GENE EXPRESSION IN MYELODYSPLASTIC NEOPLASM (SMD) AND ACUTE MYELOID LEUKEMIA MYELODYSPLASIA RELATED (AML-MR)
由: AA Vieira, et al.
出版: (2024-10-01)

Immunomodulatory Effect of Green Tea Treatment in Combination with Low-dose Chemotherapy in Elderly Acute Myeloid Leukemia Patients with Myelodysplasia-related Changes
由: Andrana K. Calgarotto, et al.
出版: (2021-03-01)

Transforming activities of the NUP98-KMT2A fusion gene associated with myelodysplasia and acute myeloid leukemia
由: James N. Fisher, et al.
出版: (2020-07-01)

MYELODYSPLASIA-RELATED CYTOGENETIC ABNORMALITES IN CHILDHOOD ACUTE MYELOID LEUKEMIA – A 20-YEAR I-BFM- AML COLLABORATIVE DATABASE STUDY
由: Kristian Juul Sandahl, et al.
出版: (2023-12-01)

Unusual CD34 positivity in acute myeloid leukaemia with myelodysplasia‐related changes with megakaryoblastic differentiation
由: Daniele Avenoso, et al.
出版: (2021-11-01)

G-CSF receptor (CSF3R) mutations in X-linked neutropenia evolving to acute myeloid leukemia or myelodysplasia
由: Karolien Beel, et al.
出版: (2009-10-01)

Myelodysplasia and acute myeloid leukemia fifteen years after high-dose cyclophosphamide in a child with severe aplastic anemia
由: José Carlos Jaime-Pérez, et al.

THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY
由: Ercole Brusamolino, et al.
出版: (2012-04-01)

THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY
由: Ercole Brusamolino, et al.
出版: (2014-08-01)

THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY
由: Ercole Brusamolino, et al.
出版: (2012-01-01)

THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY
由: Ercole Brusamolino, et al.
出版: (2014-08-01)

The −7 chromosomal abnormalities with signs of myelodysplasia in chronic myeloid leukemia as a major red signal
由: Emilie Cayssials, et al.
出版: (2019-06-01)

Myelodysplasia and Mast Cell Leukemia with t(9;22)
由: Kathryn J. Lago, et al.
出版: (2017-01-01)

Glutathione S-transferase theta 1 (GSTT1) gene defect in myelodysplasia and acute myeloid leukaemia
由: Atoyebi, W, et al.
出版: (1997)

Screening for myeloid mutations in patients with myelodysplastic syndromes and AML with myelodysplasia-related changes
由: Matheus F. Bezerra, et al.
出版: (2022-07-01)

DISTINCTION BETWEEN ACUTE MYELOID LEUKAEMIA WITH MYELODYSPLASIA-RELATED CHANGES AND MIXED-PHENOTYPE ACUTE LEUKAEMIA: A DIAGNOSTIC CHALLENGE
由: NA Marcondes, et al.
出版: (2021-10-01)

Allelic loss of IRF1 in myelodysplasia and acute myeloid leukemia: retention of IRF1 on the 5q- chromosome in some patients with the 5q- syndrome.
由: Boultwood, J, et al.
出版: (1993)

INDUCTION OF A CDS+ T CELL RESPONSE TO THE MAGE CANCER TESTIS ANTIGEN BY COMBINED TREATMENT WITH AZACITIDINE AND SODIUM VALPROATE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASIA
由: Goodyear, O, et al.
出版: (2010)

FACTORS DETERMINING CLINICAL RESPONSE TO 5 '-AZACITDINE AND SODIUM VALPROATE COMBINATION THERAPY IN PATIENTS WITH HIGH RISK ACUTE MYELOID LEUKAEMIA AND MYELODYSPLASIA
由: Craddock, C, et al.
出版: (2010)

Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens
由: John F. Seymour, et al.
出版: (2017-12-01)

Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia.
由: Goodyear, O, et al.
出版: (2010)

Vorinostat does not improve outcome in patients with acute myeloid leukemia and high risk myelodysplasia treated with azacitidine: Results of the UK Trials Acceleration Programme Ravva Trial
由: Craddock, C, et al.
出版: (2016)

Chromosomal deletions in myelodysplasia.
由: Boultwood, J, et al.
出版: (1995)

ARQ531: the therapy that targets multiple pathways in acute myeloid leukemia
由: Charlotte Hellmich, et al.
出版: (2020-10-01)

Lenalidomide monotherapy and in combination with cytarabine, daunorubicin and etoposide for high-risk myelodysplasia and acute myeloid leukaemia with chromosome 5 abnormalities.
由: Dennis, M, et al.
出版: (2013)

P494: A FIRST-IN-HUMAN STUDY OF CD123 NK CELL ENGAGER SAR443579 IN RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA, B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA OR HIGH RISK-MYELODYSPLASIA
由: Anthony Selwyn Stein, et al.
出版: (2023-08-01)